Research ArticleEndocrinology Open Access | 10.1172/jci.insight.148496
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Zhang, X. in: JCI | PubMed | Google Scholar |
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Kellogg, A. in: JCI | PubMed | Google Scholar
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Citterio, C. in: JCI | PubMed | Google Scholar |
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Zhang, H. in: JCI | PubMed | Google Scholar
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Larkin, D. in: JCI | PubMed | Google Scholar
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Morishita, Y. in: JCI | PubMed | Google Scholar |
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Targovnik, H. in: JCI | PubMed | Google Scholar
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Balbi, V. in: JCI | PubMed | Google Scholar
1Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
2Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética/Cátedra de Genética, Buenos Aires, Argentina.
3Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Inmunología, Genética y Metabolismo, Buenos Aires, Argentina.
4Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
5Department of Endocrinology and Growth, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Find articles by Arvan, P. in: JCI | PubMed | Google Scholar |
Published April 29, 2021 - More info
Complete absence of thyroid hormone is incompatible with life in vertebrates. Thyroxine is synthesized within thyroid follicles upon iodination of thyroglobulin conveyed from the endoplasmic reticulum (ER), via the Golgi complex, to the extracellular follicular lumen. In congenital hypothyroidism from biallelic thyroglobulin mutation, thyroglobulin is misfolded and cannot advance from the ER, eliminating its secretion and triggering ER stress. Nevertheless, untreated patients somehow continue to synthesize sufficient thyroxine to yield measurable serum levels that sustain life. Here, we demonstrate that TGW2346R/W2346R humans, TGcog/cog mice, and TGrdw/rdw rats exhibited no detectable ER export of thyroglobulin, accompanied by severe thyroidal ER stress and thyroid cell death. Nevertheless, thyroxine was synthesized, and brief treatment of TGrdw/rdw rats with antithyroid drug was lethal to the animals. When untreated, remarkably, thyroxine was synthesized on the mutant thyroglobulin protein, delivered via dead thyrocytes that decompose within the follicle lumen, where they were iodinated and cannibalized by surrounding live thyrocytes. As the animals continued to grow goiters, circulating thyroxine increased. However, when TGrdw/rdw rats age, they cannot sustain goiter growth that provided the dying cells needed for ongoing thyroxine synthesis, resulting in profound hypothyroidism. These results establish a disease mechanism wherein dead thyrocytes support organismal survival.
In the body, the circulating thyroid hormone, thyroxine (also known as T4) originates exclusively from biosynthesis within the thyroid gland. T4 biosynthesis occurs by a common mechanism in all vertebrates. Specifically, a monolayer of thyrocytes (also known as thyroid follicular epithelial cells) surrounds a central apical (extracellular) lumen, into which thyrocytes deliver a nearly pure secretion of thyroglobulin (Tg, encoded by the TG gene; ref. 1), which comprises ≥50% of the total protein of the thyroid gland (2). Thyrocytes exhibit a polarized distribution of plasma membrane enzymes/activities that coordinate thyroid peroxidase–catalyzed apical iodination of extracellular protein in the luminal cavity (3). Iodination of various tyrosine residues on secreted Tg (4) triggers the formation of T4 intramolecularly within the Tg protein (5, 6) prior to endocytic reentry of the hormone-containing protein into surrounding thyrocytes for lysosomal digestion, resulting in the proteolytic liberation and release of T4 from the basolateral membrane of thyrocytes to the bloodstream (7).
The first 3-dimensional atomic structure of human Tg has recently been reported (8). Already 227 different TG gene mutations have been found to be linked to congenital hypothyroidism (9); as far as is known, essentially all of the structurally defective Tg mutants are entrapped in the endoplasmic reticulum (ER), causing thyrocyte ER swelling and ER stress (10). Susceptibility to the many different pathogenic mutations is in part explained by the large and complex structure of the Tg protein (8), including its multiple repeat domains bearing internal disulfide bonds, and concluding with the cholinesterase-like (ChEL) domain (10). The C-terminal ChEL domain of Tg has no direct effect on thyroidal iodination machinery, but it (a) shares a similar structure with other ChEL family members (11), (b) provides information necessary and sufficient for the noncovalent homodimerization needed for intracellular transport (12), (c) functions as an intramolecular chaperone required to stabilize the folded structure of upstream repeat domains of Tg (13), and (d) provides its own hormonogenic iodination site (14). A number of patients have been reported with homozygous mutation in the Tg-ChEL domain (e.g., Tg-W2346R or Tg-G2322S; in the UNIPROT P01266 numbering system this would need to include the 19-residue signal peptide) with congenital hypothyroidism (15, 16).
In years past, cases of congenital hypothyroidism could go undiagnosed in early life due to insufficient neonatal screening (17). Classic studies of Marine and Lenhart showed that thyroid hyperplasia is induced as a consequence of primary hypothyroidism (experimentally induced following partial thyroidectomy or iodide deficiency) in animals (18) or humans (19); i.e., the endocrine feedback of primary hypothyroidism results in chronically upregulated pituitary secretion of thyroid-stimulating hormone (TSH), and such chronic stimulation contributes to exuberant growth of the thyroid gland (20–22). Therefore, patients with biallelic TG mutations would be expected to present, ultimately, with goiter. Interestingly, however, by linkage analysis, variants of the TG gene are linked to human hypothyroidism with or without thyroid goiter (23). Why hypothyroid patients with biallelic TG mutation (and no defect in TSH response) would not develop a goiter is unknown, although in the clinical setting, the understanding of goiter development is often confounded in patients who may or may not have received exogenous T4 treatment (24–26).
On the one hand, increased goiter growth might help to overcome genetic or acquired inefficiency of thyroid hormone synthesis (27); on the other, growth of a large goiter in iodine deficiency has been proposed to be a maladaptation (28). In either case, there has been a fundamental knowledge gap in understanding how untreated patients bearing pathogenic, biallelic TG mutations could possibly be capable of synthesizing endogenous T4.
Chronic, unremitting and unresolved ER stress is a factor that can promote cell death (29–34). Chronic ER stress is known to occur in the thyrocytes of TGcog/cog (congenital goiter) mice (encoding Tg-L2263P), which are famous for their hyperplastic goiter — and also in TGrdw/rdw (rat dwarf) rats (35) that do not develop a goiter (36). In all cases of biallelic TG mutation, it is thought that massive quantities of mutant Tg protein are blocked in forward advance from the ER, as in the TGcog/cog and TGrdw/rdw thyroid glands, triggering a dramatic ER stress response that is also seen in the thyroid glands of patients with this disease (35, 37–39). Thyrocyte cell death has never been considered in goitrous TGcog/cog mice or humans with biallelic TG mutations, but in TGrdw/rdw rats we posited that thyroid follicular cell death might block the development of goiter (40).
Importantly, untreated TGcog/cog mice spontaneously increase their levels of serum T4, paralleling growth of the thyroid gland, ultimately achieving nearly normal levels (41). With this in mind, in this report we have analyzed both rodent thyroid glands and those of individuals expressing biallelic TG missense mutations that render Tg incapable of forward trafficking from the ER. Remarkably, we found that thyrocyte cell death and disintegration within the thyroid follicle lumen provides the Tg substrate needed for synthesis of endogenous T4. The life of untreated individuals depends on this unusual mechanism of endogenous T4 synthesis, as even a brief exposure of such animals to antithyroid drugs is lethal. Most remarkably, we have uncovered compelling evidence that, in this disease, goiter growth is needed to provide an ongoing supply of dead cells so that thyroid hormonogenesis can be sustained.
Mutant mice and humans bearing biallelic TG missense mutations endogenously synthesize T4 using substrate derived from dead thyrocytes. With age, hypothyroid TGcog/cog mice (expressing homozygous Tg-L2263P) spontaneously increase their serum T4 to eventually reach nearly normal levels (41), which is perplexing because the mutant cogTg protein cannot exit the ER (37, 38). We performed routine histology of WT and TGcog/cog mouse thyroid glands. Whereas thyroid follicles from WT mice showed the normal epithelial monolayer of thyrocytes surrounding an abundant proteinaceous extracellular lumen (Figure 1A, left), thyrocytes from TGcog/cog mice exhibited enormous intracellular distention (comprising massive ER expansion, ref. 42), with nuclei abnormally “pushed” into the apical cytoplasm (Figure 1A, right). Immunofluorescence of Tg in the thyroid follicles of WT mice revealed densely packed Tg protein within the extracellular lumen (Figure 1B, top), whereas in TGcog/cog mice, Tg was detectable in an abnormal, patchy distribution in the follicle lumen (Figure 1B, bottom). On the one hand, one might expect to find Tg in the follicle lumen, because TGcog/cog mice do produce T4, and Tg is the protein from which T4 is synthesized (10). Indeed, detectable T4-containing protein was generated (in the lumen of 92.4% ± 10.9% of TGcog/cog thyroid follicles [SD, n = 7 animals]), surrounded by a ring of thyrocytes (nucleated cells positive for the thyrocyte-specific transcription factor, Pax8; Figure 1C, bottom). Thus, in TGcog/cog mice, mutant Tg can reach the lumen of thyroid follicles, in which T4 is synthesized. On the other hand, mutant Tg is not thought to be competent for anterograde transport from the ER (37). For each Tg molecule that successfully undergoes anterograde transport from the ER, approximately two-thirds of the N-glycans on each molecule acquire Golgi sugar modifications (43, 44), enabling those glycans to acquire resistance to digestion with endoglycosidase H (Endo H; ref. 45). We confirmed that in WT mice, nearly all thyroidal Tg molecules (which, in the steady-state, reside primarily in the extracellular follicle lumen) have acquired Golgi-based “complex” N-glycans and thus have become Endo H resistant (Figure 1D). In contrast, in TGcog/cog thyroid glands, no Tg acquired Endo H resistance (and instead Tg remained completely Endo H sensitive, Figure 1D). These data indicate that no cogTg undergoes intracellular trafficking to the Golgi complex. Although exosomes cannot convey Endo H–sensitive protein directly from the ER to the extracellular space (46, 47), the foregoing data do suggest that in the TGcog/cog thyroid gland, Tg must arrive in the lumen of thyroid follicles via a delivery mechanism other than the conventional secretory pathway. Interestingly, the patchy distribution of mutant Tg in the follicle lumen appeared to be associated with additional cellular material, including nuclear chromatin (Figure 1, A and B).
ER stress, cell death, and T4 synthesis in TGcog/cog mice. (A) Representative H&E-stained images of WT and TGcog/cog thyroids (n = 6 animals/group), showing thyrocyte distention with apically displaced nuclei in TGcog/cog mice compared with a thin monolayer of thyrocytes in WT (+/+) mice. Scale bars: 20 μm. (B) Representative anti-Tg immunofluorescence in thyroid glands of WT and TGcog/cog mice (n = 8 animals/group), with DAPI counterstain. Scale bars: 20 μm. (C) Representative immunofluorescence of T4-containing protein in thyroid follicles of WT or TGcog/cog mice (n = 6 animals/group). Thyrocytes are highlighted by PAX8-positive nuclear transcription factor with DAPI counterstain. Scale bars: 10 μm. (D) Endoglycosidase H digest of thyroid homogenates before SDS-PAGE and Tg Western blotting from WT and TGcog/cog mice (n = 3 animals/group; 2 of each kind shown). R, endoglycosidase H resistant; S, endoglycosidase H sensitive. (E) Top: Western blotting of BiP, p58ipk, and CHOP in the thyroids of TGcog/cog mice (n = 3–4; each lane represents 1 animal). Bottom: Quantitation of bands (normalized to tubulin), shown as mean ± SD. ***P < 0.001 (unpaired 2-tailed Student’s t test). (F) Representative TUNEL staining and immunofluorescence of T4-containing protein with DAPI counterstain in thyroid sections of WT and TGcog/cog mice (n = 7 animals/group). For clarity, in the merged image from TGcog/cog mice, a dashed white line delimits the thyroid follicle lumen. Scale bars: 20 μm. (G) Thyroid homogenate from TGcog/cog mice (n = 3) was immunoprecipitated with mAb anti-T4 in the presence or absence of T4 competitor, followed by either mock digest or Endo H digest and SDS-PAGE plus immunoblotting with mAb antibody that recognizes intact Tg. As a positive control, WT Tg secreted from PCCL3 (rat) thyrocytes was digested for Endo H resistance. The T4-containing Tg protein of TGcog/cog mice was entirely Endo H sensitive. The position of the 250 kDa molecular weight marker is shown.
The synthesis of misfolded Tg is accompanied by ER stress (38, 48–51). Ongoing ER stress in the thyroids of TGcog/cog mice was demonstrable (Figure 1E), with a dramatic elevation of ER stress markers, including the ER hsp70 chaperone BiP (52) and its cochaperone p58ipk (encoded by DNAJC3; ref. 53). Additionally, ER stress–induced upregulation of CHOP (Figure 1E) can promote cell death (54, 55). These data (and additional evidence shown below) led us to consider that T4 synthesis in TGcog/cog mice might be based on mutant Tg being delivered to the thyroid follicle lumen via thyrocyte cell death. Such a possibility is not without precedent; indeed, upon cell death in other epithelia, including renal tubular epithelial cells, mammary epithelial cells, and bronchial epithelial cells, dead cells are extruded selectively to the apical side of the epithelium (56–58), which, in the thyroid, would correspond to the follicular lumen.
In the thyroids of TGcog/cog mice, we could detect abnormal nuclear material in the lumen of 74.0% ± 22.8% (SD, n = 4 animals) of thyroid follicles, including DAPI staining, suggesting karyolysis and karyorrhexis — swollen nuclei retained in dead-cell ghosts with less intense DAPI staining, consistent with a gradual disintegration of dead cells and their chromatin. Images of cell ghosts revealed positivity for CHOP (detected in 33% ± 9.7% of thyroid follicles, Supplemental Figure 1A); cleaved caspase-3 (an executioner caspase) was detected in 30% ± 11.4% (SD, n = 4 animals) of total follicles (Supplemental Figure 1B) and was positive by TUNEL staining, indicating cleaved DNA (Figure 1F, a dashed line drawn on the merged image highlights the apical luminal cavity). Crucially, more than 96% of TUNEL-positive cell ghosts were associated with the presence of T4 synthesis (n = 4 animals; see Figure 1F). No DAPI-positive, CHOP-positive, cleaved caspase-3–positive, or TUNEL-positive cells were observed within the thyroid follicle lumen of WT mice (Figure 1F and Supplemental Figure 1, A and B).
Some of the T4 synthesized in Tg can occur within small peptide regions that do not require the native globular structure of the entire molecule (8, 59). In pilot studies using a recently developed assay for thyroid hormone formation after in vitro iodination (14) of transfected cell lysates, we observed that ER-entrapped recombinant mutant cogTg and rdwTg (described below) have the potential to serve as substrate for T4 synthesis. Immunoblotting of unpurified thyroid homogenates with anti-T4 to identify T4-containing proteins revealed the major Tg hormone–containing fragment (~250 kDa, ref. 38) and its degradation products (7) in WT mouse thyroid tissue, whereas TGcog/cog thyroid glands did not immediately reveal a clear predominant species (Supplemental Figure 1C, lanes 2–4). We selectively concentrated T4-containing protein from TGcog/cog thyroid tissue by immunoprecipitation with anti-T4, followed by immunoblotting of the recovered samples with a mAb that specifically favors recognition of intact Tg (epitope located between Tg residues 1000 and 1100). As expected, when no tissue sample was included in the anti-T4 immunoprecipitation, no T4-containing Tg protein was recovered (Supplemental Figure 1C, lane 8). However, both WT (Supplemental Figure 1C, lane 7) and TGcog/cog thyroid glands clearly demonstrated Tg bearing T4 (Supplemental Figure 1C, lanes 9–11). Moreover, whereas secreted WT Tg was entirely Endo H resistant, the Tg that was specifically immunoprecipitated from TGcog/cog thyroid tissue by virtue of its T4 content was still fully Endo H sensitive (Figure 1G). Thus, albeit inefficient, in the thyroid glands of untreated TGcog/cog mice, T4 is synthesized in vivo on mutant Tg protein that has never traversed the Golgi complex.
Similar to TGcog/cog mice, a patient bearing homozygous Tg-W2346R in the ChEL domain developed a large hypothyroid goiter, leading to thyroidectomy (15). Histological analysis of the patient’s thyroid tissue indicated the presence of abnormal nuclear and cytoplasmic profiles in follicle lumen (Supplemental Figure 2A). Cross sections of the patient’s goiter were immunostained with anti-Tg. Unlike the normal human thyroid (Figure 2A), more than 50% of thyroid follicle lumina contained the mutant Tg in an abnormal, patchy distribution that was associated with cellular material, including nuclei (Figure 2A), similar to that seen in TGcog/cog mice. Additionally, 49% of the patient’s thyroid follicles exhibited detectable cleaved caspase-3 (Figure 2B, an inner dashed line highlights the apical luminal cavity in the WT control, which is negative for cleaved caspase-3) and abnormal, weakly DAPI-positive material in the thyroid follicle lumen, consistent with various stages of nuclear disintegration (Figure 2). Indeed, residual positive signal for the Pax8 transcription factor was detectable (Figure 2C) — albeit usually at a lower level than that seen in surrounding living follicular cells (but clear enough to identify the dead cells as thyrocytes). Remarkably, ongoing T4 synthesis was detected in all of the follicles containing dead thyrocytes, with evidence suggesting endocytic recapture of T4-containing protein in an apically concentrated ring near the boundary between living thyrocytes and the luminal cavity (Figure 2C). Indeed, T4-containing substrate was prominently seen on cytoplasmic protein adjacent to the nuclei of TUNEL-positive dead thyrocytes. Additionally, the dead-cell ghosts were cannibalized (endocytosed) by surrounding live-cell neighbors, highlighting a positive ring of T4- immunostaining lining the apical region of live thyrocytes (Supplemental Figure 2, B–D). Together the data, both in rodents and humans with mutant Tg, indicate a pathological salvage mechanism of T4 synthesis that is built not upon Tg secretion but upon mutant Tg reaching the follicle lumen via exfoliation of ER-stressed, dead thyrocytes.
Tg and T4 synthesis in a homozygous patient bearing TGW2346R/W2346R. (A) Anti-Tg immunofluorescence (red) with DAPI counterstaining (blue) of human thyroid sections from a patient bearing TGW2346R/W2346R and a representative unaffected (Control) individual (n = 3). The diseased thyroid gland shows abnormal accumulation of intracellular Tg but also shows Tg in a patchy distribution in the thyroid follicle lumen. Scale bars: 10 μm. (B) Anti-cleaved caspase-3 immunofluorescence (red) with DAPI counterstaining (blue) in the thyroid gland of the individuals from A. For clarity, a dashed white line delimits the thyroid follicle lumen in the control (in which cleaved caspase-3 is not seen). Scale bars: 10 μm. (C) Immunostaining of T4-containing protein (green) in thyroid follicles from the individuals in A. Thyrocyte identity is confirmed by PAX8-positive nuclei (red) with DAPI counterstain (blue). Scale bars: 10 μm.
In hypothyroidism with biallelic mutant TG, thyroid cell mass is the critical factor regulating thyroid hormone synthesis. The adult homozygous TGrdw/rdw rat (encoding Tg-G2298R) is well-known for congenital hypothyroidism, although rather than goiter, the animal develops a hypoplastic thyroid gland (36, 60–62). As in other vertebrates, the normal rat thyroid exhibits a classic monolayer of epithelial thyrocytes surrounding a central cavity filled with secreted eosinophilic Tg (Figure 3A, left). TGrdw/rdw rat thyroid glands also form follicles surrounding a central cavity with eosinophilic content (Figure 3A, right). Although suitable antibodies were not available to confirm the apical distribution of (rat) thyroid peroxidase and DUOX2 (two enzymes that help to catalyze T4 synthesis), we could confirm that aminopeptidase-N — also known to be an apical membrane marker in thyrocytes (63, 64) — was still delivered to its correct destination in TGrdw/rdw thyroid follicles (Figure 3B, a dashed yellow line highlights the basal membrane outlining the outer boundary of thyroid follicles). Nevertheless, the TGrdw/rdw thyroid histology was far from normal — the cytoplasm was massively engorged with eosinophilic vacuoles displacing nuclei under the apical plasmalemma, and the staining of the follicle lumen was abnormally heterogeneous (Figure 3A, right). The eosinophilic vacuoles are in fact ER (60) filled with the ER molecular chaperone, BiP (Figure 3C). Whereas more than 85% of Tg molecules in WT rats were Endo H resistant, analysis of TGrdw/rdw thyroid glands (n = 4) showed that the fraction of Tg molecules bearing Endo H resistance was 0, indicating an inability of mutant Tg to undergo intracellular transport to the Golgi complex (e.g., Figure 3D), as previously reported (65). Nevertheless, 64.5% ± 18.5% (SD, n = 6 animals) of TGrdw/rdw thyroid follicles exhibited mutant Tg in the lumen — associated with whole-cell profiles (Figure 3E) that upon close histological inspection indicated the presence of thyrocytes at different stages of cell death (Supplemental Figure 3A).
Tg is entrapped in the ER, yet it reaches the thyroid follicle lumen in TGrdw/rdw rats. (A) Representative H&E-stained images of thyroid glands from WT (+/+) and TGrdw/rdw rats (n = 6 per group), showing abnormally heterogeneous eosinophilic content in the follicle lumen, surrounded by abnormally swollen thyrocytes in TGrdw/rdw rats. Scale bars: 20 μm. (B) Representative distribution of aminopeptidase N by immunofluorescence (green) with DAPI counterstain (blue) in thyroid follicles of WT and TGrdw/rdw rats (n = 4 per group). For clarity, a yellow dotted line highlights the outer boundary of the thyroid follicular cells. Scale bars: 10 μm. (C) Representative distribution of BiP by immunofluorescence (red) with DAPI counterstain (blue) in thyroid follicles of WT and TGrdw/rdw rats (n = 4 per group). Scale bars: 10 μm. (D) Representative thyroid homogenates from WT and TGrdw/rdw rats were either mock digested or digested with endoglycosidase H (Endo H), followed by SDS-PAGE and immunoblotting with anti-Tg (n = 4 animals per group). No Tg from TGrdw/rdw rats was endo H resistant. (E) Representative distribution of Tg in the thyroid follicle lumen by immunofluorescence (green) with DAPI counterstain (blue) from WT and TGrdw/rdw rats (n = 7 per group). Scale bars: 20 μm.
As in humans and mice with congenital hypothyroidism with mutant Tg, T4-containing protein — while dramatically diminished relative to that found in WT thyroid follicles — was apparent in the lumen of 89.7% ± 13.3% (SD, n = 5 animals) of the thyroid follicles of untreated TGrdw/rdw rats (Figure 4), surrounded by a monolayer of Pax8-positive cells (indicative of thyrocytes, Figure 4A). This T4-containing protein signal was specific, as it (a) could not be detected in the parotid salivary gland (that expresses sodium-iodide symporter but cannot iodinate proteins, Supplemental Figure 3B); (b) was fully blocked when adding soluble levoT4 competitor during the immunofluorescence protocol (Figure 4B, a dashed white line highlights the apical luminal cavity and a dashed yellow line highlights the basal membrane outlining the outer follicle boundary); and (c) was diminished in the thyroids of TGrdw/rdw rats fed chow containing propylthiouracil (which inhibits thyroid iodination, Supplemental Figure 3C). We could not continue the experiment to complete depletion of thyroidal T4-containing protein because within 4 weeks of treatment with the antithyroid drug, the animals became moribund and died spontaneously, indicating that ongoing endogenous T4 synthesis is required to avoid postnatal lethality.
T4 synthesis in TGrdw/rdw rats. (A) Representative immunofluorescence of T4-containing protein (green) in the thyroid follicle lumen of WT (+/+) and TGrdw/rdw rats (n = 5 animals per group). Thyrocyte identity is confirmed by PAX8-positive nuclei (red) with DAPI counterstain (blue). Scale bars: 20 μm. (B) Representative immunofluorescence detection of T4-containing protein (green; with DAPI counterstain in blue) in the thyroids of WT and TGrdw/rdw rats (n = 9 animals per group) was specifically blocked by addition of T4 competitor (1 μg/mL). For clarity, a dashed white line delimits the thyroid follicle lumen; a yellow dotted line highlights the outer boundary of the thyroid follicle. Scale bars: 10 μm.
We examined ER stress responses in TGrdw/rdw thyroid glands. PERK phosphorylation of eIF2α stimulates increased translation of ATF4 that upregulates CHOP, which (as noted above) has been strongly implicated in cell death (29). In addition to a dramatic increase of BiP and p58ipk, TGrdw/rdw thyroid glands were observed to have increased phosphorylated eIF2α (Figure 5A), accompanied by a more than 10-fold increase of CHOP mRNA (Figure 5B). A second ER stress–related death pathway involves IRE1 hyperactivation that can trigger a “terminal UPR” from exuberant RNAse activity (“RIDD”), which typically develops only in cells exhibiting demonstrably high levels of stress-induced IRE1 splicing of XBP1 mRNA (66). We observed that roughly half of thyroidal XBP1 mRNA was spliced to the active form in TGrdw/rdw animals (Figure 5C), which is impressive considering that thyrocytes and C cells together constitute only approximately 60% of resident cells in the mouse thyroid (67); i.e., these are conditions that can favor a terminal UPR. Moreover, TUNEL-positive cells were present in the follicular lumina of TGrdw/rdw thyroid glands. Indeed, the thyroid follicles of untreated TGrdw/rdw rats exhibited ongoing T4 synthesis (Figure 5D), with 27.2% ± 5.3% (SD, n = 3 animals) of all follicles triply positive for weak DAPI staining, TUNEL, and T4-containing protein; a positive signal for cleaved caspase-3 was also detected in 24.8% ± 9.4% of thyroid follicles (SD, n = 5 animals), although none of these features were detected in WT thyroid (Figure 5E). Caspase activity can cleave the DNA repair enzyme poly(ADP-ribose) polymerase (PARP), and unlike in WT thyroid tissue, PARP was extensively cleaved in TGrdw/rdw thyroid glands (Figure 5F).
ER stress, cell death, and T4 synthesis in TGrdw/rdw rats. (A) Left: BiP, p58ipk, and phospho-eIF2α Western blotting in thyroids of WT (+/+) and TGrdw/rdw rats (each lane represent 1 animal). Right: Quantification (BiP and p58ipk normalized to tubulin; phospho-eIF2α normalized to total eIF2α; mean ± SD). **P < 0.01, ***P < 0.001 (unpaired 2-tailed Student’s t test). (B) CHOP mRNA levels (normalized to YWHAZ) in the thyroid glands of WT and TGrdw/rdw rats (n = 7–8 animals/group; each point represents 1 animal; mean ± SD). ***P < 0.001 (unpaired 2-tailed Student’s t test). (C) Top: Representative samples showing spliced and unspliced XBP1 mRNA in the thyroids of WT, TGrdw/+, and TGrdw/rdw rats (n = 3–6 animals/group; each lane represents 1 animal). Hprt1 was used as a loading control. Bottom: Quantitation of the fraction of spliced XBP1 (mean ± SD). **P < 0.01, ***P < 0.001 (1-way ANOVA, Bonferroni post hoc test). (D) Representative TUNEL staining and immunofluorescence of T4-containing protein with DAPI counterstain in the thyroids of WT and TGrdw/rdw rats (n = 4 animals/group). Scale bars: 20 μm. (E) Representative immunofluorescence of cleaved caspase-3 with DAPI counterstain in thyroids of WT and TGrdw/rdw rats (n = 5 animals/group). For clarity, a dashed white line delimits the thyroid follicle lumen in the WT rats (in which cleaved caspase-3 is not detectable). Scale bars: 20 μm. (F) Western blotting of PARP in thyroid glands from WT and TGrdw/rdw rats (n = 3–4; each lane represents 1 animal). (G) Left: Representative Western blotting of T4-containing protein in thyroid homogenates of WT and TGrdw/rdw rats (n = 5 animals/group) with or without soluble competitor T4 to block specific bands (left of dotted red line). Right: The same samples immunoblotted with mAb anti-Tg showing intentional overloading of the TGrdw/rdw rat sample.
We performed Western blotting of total thyroidal proteins with anti-T4. Despite the presence of background bands, an approximately 330 kDa band comigrating with WT Tg was the clearest T4-containing protein specifically identified in the thyroid tissue of untreated TGrdw/rdw rats. The intensity of this band was completely eliminated by the addition of free T4 competitor to the antibody incubation during Western blotting (Figure 5G, left). The efficiency of T4 formation in this protein indicative of mutant Tg was much less than in the Tg protein from WT rat thyroid glands, especially when considering that more Tg protein was loaded for the mutant sample (Figure 5G, right). Altogether, the data in Figures 3–5 support that TGrdw/rdw rats also use dead thyrocytes for endogenous T4 synthesis on mutant Tg.
To more clearly examine the disintegration of dead thyrocytes bearing mutant Tg, fixed and post-fixed WT and TGrdw/rdw thyroid tissue were embedded in plastic for semithin sectioning. As expected, WT thyroid revealed dense, uniformly stained colloid (Tg protein) in the follicle lumen (Figure 6A). In contrast, in the thyroids of TGrdw/rdw rats, in addition to large vacuoles in the basal cytoplasm with apically displaced nuclei, the lumen of different follicles varied, with contents ranging from whole cells to cellular debris (Figure 6B). Moreover, electron microscopy revealed that living follicular thyrocytes had massively swollen ER with unusual nuclear morphology, and most of the remaining organelles were crowded into the apical cytoplasm, ultimately limited by the apical plasma membrane bearing microvilli that extend into the follicle lumen (Figure 6C). Cell ghosts with disintegrating organelles were readily apparent in many of the follicle lumina examined (e.g., Figure 6D), surrounded by epithelial cells bearing dense endo-lysosomes (Figure 6, E and F), suggesting that dead-cell material from the follicle lumen enters surrounding living thyrocytes via endocytic internalization, with progressive clearance of the detritus of dead-cell ghosts (Figure 6, G and H).
In congenital goiter with mutant TG, thyrocyte cell mass provides the dead-cell–derived substrate for T4 synthesis. (A–H) Microscopy of WT and TGrdw/rdw rat thyroid follicles. (A) WT rat thyroid. Cross-sections of several thyroid follicles are shown; each follicle lumen (F.L.) is acellular but filled with WT Tg protein (thin yellow arrows). Scale bar: 10 μm in 1.0 μm increments. (B) TGrdw/rdw rat thyroid. Yellow arrows point to the follicle lumina; note the enlarged cytoplasm and abnormal, cellular contents of the follicle lumina. Scale bar: 10 μm in 1.0 μm increments. (C–H) Transmission EM survey of TGrdw/rdw rat thyroid follicles. Scale bars: 2 μm. (C) Engorged ER vacuoles in the basal cytoplasm with apically displaced nuclei. (D–H) Dead-cell ghosts in various thyroid follicles, each at a different stage of cellular disintegration within the follicle lumen. (G) Living thyrocytes with abundant apical microvilli, which have internalized material from the follicle lumen into endo-lysosomes. (H) Until new dead cells enter the follicle lumen, there is progressive clearance of cellular debris from the luminal cavity. (I) Thyroid gland size (normalized to body weight) in a cohort of young versus older animals (open symbols represent rats at 8.9 ± 1.7 weeks of age; closed symbols represent rats at 33.4 ± 2.6 weeks of age; males are shown as squares and females as circles) (mean ± SD). ***P < 0.001 (2-way ANOVA, Bonferroni post hoc test). (J) Total T4 levels in serum of WT (+/+) and TGrdw/rdw rats as a function of age (males are shown as squares and females as circles) (mean ± SD). **P < 0.01, ***P < 0.001 (2-way ANOVA, Bonferroni post hoc test).
A great puzzle in the field has been understanding why some patients (and some animal models) with biallelic TG mutations that grow a large goiter can yield a survivable serum T4 level without treatment, yet other patients and animals models with an intact hypothalamic-pituitary-thyroid axis are unable to do so (68). With this question specifically in mind, we examined thyrocyte proliferation in hypothyroid TGrdw/rdw rats. Indeed, in early life we observed that TGrdw/rdw rats did indeed exhibit active proliferation of thyrocytes, similar to that observed in TGcog/cog mice (Supplemental Figure 4A). Indeed, although never previously described, we observed that in early life TGrdw/rdw rats do in fact develop thyroid enlargement (i.e., goiter) by 9 weeks of age (Figure 6I), and this parallels a significant increase of endogenous T4 synthesis that supports serum T4 levels (Figure 6J). However, as the TGrdw/rdw animals aged, the enlarged thyroid gland size could not be sustained (Figure 6I), and with this (61), the animals could not maintain their serum T4 levels (Figure 6J). Untreated profound hypothyroidism is ultimately incompatible with life in rodents (noted above, and refs. 69, 70) as well as in humans. It thus appears that only patients and animal models that can support a sufficient goiter are able to provide the continuous supply of dead thyrocytes needed for ongoing T4 synthesis — a mechanism that can allow some individuals the chance to sustain endogenous thyroid hormone levels in adulthood (24).
Reports describe untreated adult patients with a large goiter who are biochemically and clinically nearly euthyroid despite biallelic TG deficiency (71–73). Two longstanding but competing schools of thought are that (a) a large hyperplastic goiter is a compensatory physiological adaptation in response to thyroidal genetic or environmental factors that disfavor thyroid hormone production (74) or (b) growth of a large thyroid goiter is actually a maladaptation (28). On the one hand, because the Tg protein is the evolutionarily preferred thyroid hormone precursor (1), and because the mutant TG alleles encode a Tg protein that cannot be exported via the secretory pathway from the ER to the site of iodination (2, 10), simply enlarging the thyroid gland does seem pointless. On the other hand, in this disease, there are reasons favoring a positive correlation between thyroid follicular cell mass and the overall synthesis of T4 needed to sustain serum T4 levels (41).
The main finding of this report is that, in humans and animals with biallelic mutant TG, T4 biosynthesis continues as long as the thyroid follicle lumen is provided with a supply of dead or dying thyrocytes (see schematic cartoon, Supplemental Figure 4B). Throughout the course of the disease, a fraction of the ER-stressed thyrocytes die and are extruded to the luminal cavity, temporarily including activation of caspase-3, cleavage of PARP, and DNA cleavage leading to nuclear fragmentation and karyolysis, ultimately leading to complete disintegration of cellular organelles within the iodination environment of the follicle lumen. Death of thyrocytes is asynchronous, chronic, and heterogenous during the course of the disease, such that at any moment in time, cells at various stages of demise are observed across the gland, surrounded by living cells that maintain a follicular architecture enclosing iodoproteins within the apical cavity. Our analysis did not include specific detection of inflammatory cell infiltration of thyroid follicles but rather ER stress throughout the entire population of living mutant thyrocytes, with remnant detection of ER stress (e.g., CHOP) in the dead-cell ghosts. Crucially, in this disease, it is the dead, disintegrating thyrocytes upon which T4-containing protein can be detected, with the thyroid follicles cannibalizing (internalizing) the iodinated detritus of dead thyrocytes into the surrounding living follicular cells.
The spectrum of proteins upon which T4 might be made inefficiently in humans with biallelic TG mutation has not yet been fully explored, although it has often been speculated that albumin, which can become highly iodinated (75) as a serum protein capable of transcytosis (76) or paracelllular leakage (75), could perhaps be a source of endogenous T4. Given the mechanistic understanding presented in the current study, we recognize that the entire proteome leaked from dead thyrocytes becomes eventually exposed to the iodination environment. Here, we show that even though the mutant Tg protein cannot be secreted via conventional intracellular trafficking (77), it is nevertheless conveyed to the lumen of thyroid follicles via dead thyrocytes, wherein T4 is produced (albeit inefficiently) within the mutant Tg protein in TGcog/cog mice, TGrdw/rdw rats, and, most likely, humans with the same disease.
Indeed, this pathological salvage mechanism of T4 synthesis is observed in the goitrous thyroid gland of a patient with homozygous expression of Tg-W2346R. Moreover, in this study, we provide strong supporting evidence that total thyroid cell mass (i.e., the goiter) is important for the endogenous rescue from hypothyroidism. Specifically, increasing amounts of T4 are produced as the thyroid begins to grow postnatally (41); however, in TGrdw/rdw rats, profound hypothyroidism ensues in parallel with an atrophic thyroid gland (36, 61). Thus, our results demonstrate that TGrdw/rdw rats form a goiter but cannot sustain their goiter with aging. Evidently, without the growing goiter, the thyroid gland cannot provide sufficient dead cells needed to fuel ongoing thyroid hormone production. These considerations make it clear that the balance of cell proliferation-versus-death is indeed a critical factor, as ultimately, an unfavorable balance in TGrdw/rdw rats deprives the thyroid of sufficient substrate to maintain T4 synthesis. In contrast, continued growth of the goiter in TGcog/cog mice allows this pathological salvage mechanism to endogenously self-correct the hypothyroidism (41), and human studies suggest a similar conclusion in patients with a goiter with biallelic TG mutations.
More work is needed to determine if rdwTg might somehow be more proteotoxic than cogTg (40) or if other factors that vary between species drive the enhanced capability of TGcog/cog mice for a net proliferation of thyrocytes (i.e., in excess of cell death) into adulthood. What is apparent in all cases, however, is that the continuous contribution of dead and dying thyrocytes, which provide substrate for T4 production, represents the critical compensatory response to congenital hypothyroidism with biallelic TG mutations. Moreover, as a brief exposure to antithyroid drug is lethal to TGrdw/rdw rats, our findings appear consistent with the hypothesis that in the presence of biallelic TG mutations, survival of the organism (8, 68) does require this most unusual means of thyroid hormonogenesis.
Primary antibodies. Anti-Ki67 (SP6) (ab16667, Abcam); anti–cleaved caspase-3 (Asp175) antibody (9661, Cell Signaling); anti-CHOP (sc-7351, Santa Cruz); anti-T4 (1H1) (sc-52247, Santa Cruz); mAb anti-Tg (365997, Santa Cruz; ab156008, Abcam); rabbit anti-Tg and rabbit anti-BiP were previously described (38, 45); rabbit anti-Pax8 (10336-1-AP, ProteinTech Group); mAb anti-Aminopeptidase N (1D7) was the gift of D. Fox, University of Michigan (78); rabbit anti-p58ipk (2940, Cell Signaling Technology); rabbit anti-phospho-eIF2α (Ser51) (3597, 9721, Cell Signaling) and total eIF2α (9722, Cell Signaling); mouse anti-tubulin (T5168, MilliporeSigma); and rabbit anti-PARP (9542, Cell Signaling).
Human thyroid sections. A homozygous patient bearing the TG-W2346R mutation was previously described (including parental written informed consent and appropriate IRB approval, ref. 15). Paraffin blocks of deidentified surgically resected thyroid tissue, including large regions of normal human thyroid from 3 now-deceased patients, were obtained from the Molecular Pathology Research Laboratory, University of Michigan, and were sectioned and H&E stained or processed for immunofluorescence as described below.
Animals. TGcog/cog mice (C57BL/6) were from JAX. TGrdw/+ rat heterozygotes were obtained from the National BioResource Project in Japan (NBRP rat no. 0104) and bred to homozygosity; WT animals were littermates of the same strain background. Adult 2- to 4-month-old mice were used in all studies, except in Figure 1G, Supplemental Figure 1C, and Supplemental Figure 4 (in which 9- to 16-month-old mice with larger goiter were used for better yield of T4-containing proteins and Ki67-positive thyrocytes). Four- to eighteen-week-old rats were used in all studies (i.e., after weaning), except in Figure 6, I and J, in which detailed ages are shown. In all figures, data from male and female animals were combined, except in Figure 6, I and J, in which results from each individual animal are shown.
Cell culture. PCCL3 cells (79) (B. DiJeso, University of Salento, Lecce, Italy) were maintained in DMEM/F-12 with 5% fetal bovine serum, 1 mIU/mL thyrotropin, 1 μg/mL insulin, 5 μg/mL apo-transferrin, 1 nM hydrocortisone (4 hormones obtained from MilliporeSigma), and penicillin/streptomycin. PCCL3-conditioned media containing secreted TG were collected as a positive control for Endo H–resistant TG.
Thyroid gland size measurement. Thyroids of euthanized animals were dissected, with both lobes of the gland fully exposed. Images of the neck were captured with a calibrated size marker included in situ. The areas of the thyroid glands (correlated with volume) were measured using ImageJ (NIH) and quantified as a fraction of body weight of each animal.
Serum total T4 measurement. Whole blood was collected, clotted, and centrifuged at 750g for 20 minutes to obtain serum. Total T4 was assayed by ELISA (Diagnostic Automation/Cortez Diagnostics).
Preparation and immunostaining of thyroid sections. Thyroid glands from mice and rats were immersion-fixed with 10% formalin and processed for paraffin embedding, sectioning, and H&E staining. For immunofluorescence, 6 μm sections were deparaffinized in Citrisolv and an ethanol series, then heated in citrate buffer (12.3 mM, pH 6) for antigen retrieval, and blocked in 1.5% normal goat serum for 30 minutes at room temperature. Primary antibody incubation was performed overnight at 4°C, followed by incubation of Alexa Fluor–conjugated secondary antibodies (Thermo Fisher). After washing, sections were counterstained and mounted with Prolong-Gold and DAPI (Invitrogen). Images were captured in a Nikon A1 confocal microscope. For anti-Ki67 immunohistochemistry, the VECTASTAIN ABC Kit (Vector) was used. After antigen retrieval, sections were treated with 3% H2O2, blocked in 1.5% normal goat serum for 20 minutes at room temperature, and incubated with anti-Ki67 antibody for 1 hour at room temperature and biotinylated secondary antibody for 30 minutes, followed by incubation with avidin-HRP. Staining was visualized by DAB reaction. Sections were counterstained with hematoxylin, dehydrated in a graded series of ethanol, and mounted with Permount. Images were obtained with a Leica DMI-3000B microscope.
T4 immunofluorescence/TUNEL double labeling. The ApopTag In Situ Apoptosis Detection Kit (Millipore) was used for TUNEL staining of thyroid sections. Minor modifications were applied for double immunofluorescence labeling with anti-T4. Briefly, deparaffinized thyroid tissue sections were pretreated with proteinase K (20 μg/mL) and blocked in 1.5% normal goat serum for 30 minutes at room temperature. Incubation with anti-T4 antibody was performed at room temperature for 1 hour, followed by incubation with Alexa Fluor 488–conjugated secondary antibody for 30 minutes at room temperature. After washing, TUNEL staining was performed. Sections were counterstained and mounted with Prolong-Gold and DAPI (Invitrogen). Fluorescence images were captured in a Nikon A1 confocal microscope.
Endo H digest. Thyroid homogenates from WT or mutant mice and rats were boiled in denaturing buffer containing 0.5% SDS and 40 mM dithiothreitol (DTT) at 95°C for 5 minutes, cooled, and then either mock digested or digested with Endo H (1000 units, NEB) for 1 hour at 37°C.
Western blotting. Rodent thyroid glands were homogenized in RIPA buffer (25 mM Tris•HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, Thermo Fisher Scientific), including either protease inhibitor cocktail (Roche) or protease-plus-phosphatase inhibitor cocktail (Thermo Fisher Scientific). Total protein concentration was determined by BCA assay (Thermo Fisher Scientific). Lysates were boiled in SDS-gel sample buffer with 50 mM DTT. Samples were then resolved by SDS 4.5%-PAGE or SDS 4%–12%-PAGE, electrotransferred to nitrocellulose, and blocked with 5% milk before immunoblotting with the indicated antibodies and appropriate HRP-conjugated secondary antibody, and visualized by enhanced chemiluminescence. Band quantitation was performed using ImageJ (NIH).
Immunoprecipitation analysis of T4-containing protein. Mouse thyroid glands were homogenized in RIPA buffer plus protease inhibitor cocktail (Roche). Thyroid homogenates were incubated with mAb anti-T4 antibody and protein G-agarose (Exalpha Biologicals) overnight at 4°C. Precipitates were washed 3 times in RIPA buffer (and for samples to be digested with Endo H, 1 additional washes in PBS) and then boiled in SDS gel–sample buffer containing 50 mM DTT, resolved by SDS 4.5%-PAGE or SDS 4%–12%-PAGE, electrotransferred to nitrocellulose, and immunoblotted with anti-T4 or anti-Tg antibody.
PCR. Total RNA was purified from the thyroid gland tissue or PCCl3 cells using a RNeasy Plus kit (Qiagen). Synthesis of cDNA was performed using SuperScript III First-Strand Synthesis SuperMix (Invitrogen) or High-Capacity cDNA Reverse Transcription Kits (Thermo Fisher Scientific). For XBP1 splicing analysis, the primers below were designed to encompass the IRE1 cleavage site of XBP1: forward primer, 5′-TGGCCGGGTCTGCTGAGTCCG-3′, and reverse primer, 5′-ATCCATGGGAAGATGTTCTGG-3′. The amplicons, including the spliced (71 bp) and unspliced (97 bp) XBP1, were generated using the GoTaq Green Master Mix Kit (Promega). PCR products were resolved by a 3% agarose gel. Hypoxanthine phosphoribosyltransferase 1 (Hprt1) was used as a control, amplified using the following primers, and loaded as a loading control: forward primer, 5′-CTCATGGACTGATTATGGACAGGA-3′, and reverse primer, 5′-GCAGGTCAGCAAAGAACTTATAGCC-3′. Band quantitation was performed using ImageJ (NIH). For real-time PCR, TaqMan Universal Master Mix was used on a StepOnePlus PCR system (Thermo Fisher Scientific). CHOP gene expression was normalized to that of Ywhaz; both probes were from TaqMan Gene Expression Assays (Thermo Fisher Scientific).
Electron microscopy of rat thyroid glands. WT and rdw/rdw rats were briefly perfusion fixed with HEPES-buffered 2% glutaraldehyde before thyroid dissection and continuing as immersion fixation. The tissues was then washed in 100 mM Na cacodylate containing 2 mM CaCl2, before postfixation with 0.25% OsO4, further washing, and staining with 0.5% uranyl acetate. After additional washes, the tissue was dehydrated in a graded series of ethanol (50%, 75%, 95%, and 100%) followed by a 30-minute incubation in propylene oxide. The tissue was finally infiltrated with Araldite in propylene oxide and then pure Araldite, which was polymerized under heating. 10 μm plastic sections were stained with 1% toluidine blue and examined by light microscopy (×100 objective); then 0.5 μm sections were picked up and placed on Formvar-coated copper grids. If not, edit for clarity, poststained with 1% lead citrate, and rinsed prior to examination in a JEOL-JEM-1400 transmission electron microscope.
Statistics. Statistical analyses were calculated using GraphPad Prism. Data are represented as mean ± SD. Unpaired 2-tailed Student’s t test was used for comparisons between 2 groups. One-way ANOVA with Bonferroni post hoc test was used for comparison of 3 groups. Thyroid size and serum T4 measurements were analyzed by 2-way ANOVA with Bonferroni post hoc test. Statistical significance was determined at P < 0.05.
Study approval. All experiments performed with mice and rats were in compliance with and approved by the University of Michigan Institutional Animal Care and Use Committee (PRO00009936). The patient thyroid block was obtained with parental written informed consent and IRB approval from the University of Buenos Aires (CEIC FFyB: 1704 2019-85; ref: EXP-FYB, no. 0067072/2018).
XZ, CEC, YM, and PA designed the experiments. XZ, APK, and CEC performed. the experiments, with assistance provided by HZ and DL. HMT and VAB provided key reagents. wrote the Methods. PA supervised the work and wrote the manuscript. All authors reviewed, edited, and approved the manuscript.
This work was supported by NIH R01DK40344 and the University of Michigan Protein Folding Diseases Initiative (to PA) and by American Thyroid Association ATA-2018-012.R1 (to CEC). We are deeply grateful to John E. Heuser and Tatyana Tenkova (Section on Integrative Biophysics, National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA) for their invaluable assistance with plastic embedding, imaging of semithin plastic sections (light microscopy), and transmission electron microscopy. We acknowledge the Michigan Histology Core Facility for assistance with sample preparation. We also thank Wen Jing and other members of the Arvan lab for comments and help.
Address correspondence to: Peter Arvan, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Brehm Tower, Room 5112, 1000 Wall Street, Ann Arbor, Michigan 48105, USA. Phone: 734.936.5505; Email: parvan@umich.edu.
Conflict of interest: The authors have declared that no conflict of interest exists.
Copyright: © 2021, Zhang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Reference information: JCI Insight. 2021;6(11):e148496.https://doi.org/10.1172/jci.insight.148496.